Both ALKBH5 and FTO can regulate the cancer epigenome through demethylation of mRNA m6A, leading to changes in the ability of cells to survive, proliferate, invade, and metastasize as alterations in drug sensitivity, cancer stem cell status, and cancer immunity. The gene discussed is FTO; the disease is cancer.